Maria Quintos Baggstrom, MD

Maria Quintos Baggstrom, MD

Professor

Address:
Division of Oncology
Mail Stop 8056-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110

11th Floor Mid Campus Center (office)

Admin:
Sara Meyer
sara.m@wustl.edu

Clinical Interests
  • Thoracic oncology
  • Clinical trial methodology
  • Medical education
Research: Involvement in clinical trials and grants

Principal Investigator of a national, multicenter clinical trial of AT-101 in small cell lung cancer supported by National Cancer Institute Cancer Therapeutics Evaluation Program, 2007- 2011.  Published 2011.

National co-Principal Investigator/Chair of a national, multicenter clinical trial of sunitinib in non-small cell lung cancer through the Cancer and Leukemia Group B (CALGB)/Alliance oncology cooperative group, 2008-present. Published May 2017.

Member, Washington University Siteman Cancer Center, 2005 – present.  Serve currently as Principal Investigator and Co-Investigator on several clinical trials in thoracic oncology.

Site principal investigator, CALGB 30504 (NCT00453154): Combination Cisplatin, Etoposide with or without Maintenance Sunitinib Malate (IND 74019 NSC 736511) for Untreated Extensive Stage Small Cell Lung Cancer: A Phase IB/Randomized Phase II Study. (Cooperative Group). Published 2015.

Site principal investigator, CALGB CIRB 30610 (NCT00632853): Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also receiving Cisplatin and Etoposide. (Cooperative Group). Ongoing.

Site principal investigator, CALGB 30801 (NCT 01041781): A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer. (Cooperative Group). Published May 2017.

Site principal investigator, 201105207 (NCT00921310): A Phase I/II Trial of Temsirolimus and Pemetrexed in Recurrent/Refractory Non-small Cell Lung Cancer (NSCLC). (Institutional, Primary). Published January 2016.

Site co-investigator, several industry sponsored trials in chemotherapeutic agents in the treatment of non-small cell and small cell lung cancer.

Co-Investigator (5% support), NIH R01MD015720, PI: Liu/Lian, Title: Healthcare Access Dimensions and Racial Disparities in Lung Cancer, September 2021-May 2025, Total Award $1,575,000.

Profiles (publications)
WU Physician Bio

Biosketch

Education

  • 1996: MD, University of Texas Medical School, Houston, TX
  • 1991: BA with Honors in Chemistry, Williams College, Williamstown, MA

Post-Graduate Training

  • 2002-1999: Fellowship, Adult Hematology/Oncology, University of North Carolina Affiliated Hospitals, Chapel Hill, NC
  • 1999-1996: Residency, Internal Medicine, University of North Carolina Affiliated Hospitals, Chapel Hill, NC

Academic Positions

  • present-2013: Associate Professor, Section of Medical Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
  • 2013-2005: Assistant Professor, Section of Medical Oncology, Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
  • 2004-2002: Clinical Instructor, Division of Hematology/Oncology, Department of Internal Medicine, University of North Carolina, Chapel Hill, NC

Leadership Roles

  • present-2022: Chair, Membership, American Society of Clinical Oncology (ASCO) Community of Practice Medical Educators
  • present-2022: Lead Author, Association of American Medical Colleges (AAMC) Group on Women in Medicine and Science (GWIMS) Toolkit Update on Equity in Promotion
  • present-2020: Associate Editor, Editorial Board, American Society of Clinical Oncology (ASCO) Digital Education
  • present-2019: Co-Program Director, Peer Mentoring Program of Mid-Career Faculty, Department of Medicine, Washington University
  • present-2019: Faculty Rights Committee, Washington University School of Medicine
    • Chair, 2021-2020
    • Vice-Chair, 2020-2019
  • present-2019: Membership Advisory Committee, American Society of Clinical Oncology (ASCO)
    • Chair, 2022-2021
    • Chair-Elect, 2021-2020
  • present-2017: Co-Chair, Schwartz Center Rounds, BJH Ethics Committee
  • present-2016: Medical Director, Barnes Jewish Hospital Cancer Care Clinic
  • present-2016: Steering Committee, Forum of Women in Medicine, Department of Medicine, Washington University
  • present-2016: Founder and Co-Chair, Women in Oncology & Hematology, Department of Medicine, Washington University
  • present-2015: Executive Committee of the Faculty Council, Clinical Representative, Washington University School of Medicine
    • Liaison to Executive Faculty Council, present-2019
    • Chair, 2021-2020
    • Vice-Chair, 2020-2019
    • Vice-Chair elect, 2019-2018
    • Clinical Representative, 2018-2015
  • 2022-2021: Medical Director, Barnes Jewish Hospital mAb Clinic
  • 2022-2021: Steering Committee, ASCO Oncology Scholars Internship (OSI) Initiative
  • 2021-2020: Governance committee, Washington University School of Medicine
  • 2020-2019: Women Faculty Leadership Development Institute, Vice-Provost for Faculty Advancement and Institutional Diversity, Washington University
  • 2020-2019: Academic Affairs Committee, Washington University School of Medicine
  • 2019-2018: Scholar, American Society of Clinical Oncology (ASCO) Education Scholars Program
  • 2018-2017: Member, Siteman Cancer Center Representative, National Comprehensive Cancer Network (NCCN) Esophageal and Gastric Cancers Panel

University & Hospital Appointments & Committees

  • present-2019: Faculty Wellness Task Force, Washington University
  • present-2018: Medical Staff Bylaws Committee, Barnes Jewish Hospital
  • present-2018: Conflicts of Interest Review Committee, Washington University
  • present-2016: Women in Oncology & Hematology, Co-Chair, Washington University
  • present-2015: Forum of Women in Medicine, Washington University
    • Steering Committee, present-2016
  • present-2012: Academic Women’s Network (AWN), Washington University
  • present-2010: Schwartz Center Rounds Planning Committee, Subcommittee of Ethics Committee, Washington University
    • Co-Chair, present-2017
  • present-2005: Ethics Committee, Washington University
  • present-2006: Institutional Review Board/Human Research Protection Office, Washington University
  • 2019-2017: Clinical Contracts Task Force, Member, Washington University
  • 2019-2016: Faculty Hiring and Employment Culture Workgroup, Washington University
  • 2018-2012: Oncology Therapeutics Subcommittee, Barnes-Jewish Hospital Pharmacy and Therapeutics Committee
  • 2018-2005: Alvin J. Siteman Cancer Center Quality and Safety Monitoring Committee, Subcommittee of Protocol and Review Monitoring Committee, Washington University
  • 2015-2010: Barnard Health & Cancer Information Center, Professional Advisory Committee

Board Certification

  • present-1999: Internal Medicine
  • present-2004: Medical Oncology

Honors & Awards

  • present-2021: Connolly Top Doctors
  • present-2017: Best Doctors in America
    • 2014-2007
  • present-2014: Fellow, American College of Physicians
  • 2021-2015: ASCO-Sponsored Cancer Interest Group, Supported by the Conquer Cancer Foundation of ASCO Mission Endowment
  • 2019-2018: American Society of Clinical Oncology (ASCO) Education Scholars Program
  • 2002: American Society of Clinical Oncology Merit Award

Editorial Responsibilities

  • present-2020: Associate Editor, Editorial Board, American Society of Clinical Oncology (ASCO) Digital Education
  • 2009: Assistant Editor, Govindan R (ed). DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology Review, 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2009

Professional Societies & Organizations

  • present-2014: Association of American Medical Colleges
    • Group on Faculty Affairs, present-2018
    • Group on Educational Affairs, present-2018
    • Alliance for Academic Internal Medicine (AAIM) member, present-2018
    • Equity in Academic Promotions Task Force, present-2017
    • Group on Women in Medicine and Science, present-2014
  • present-2003: International Association for the Study of Lung Cancer
  • present-2003: Alliance for Clinical Trials in Oncology/Cancer and Leukemia Group B (CALGB)
    • Member, Respiratory Committee, 2019-2008
    • Ad Hoc Auditor, CALGB Data Audit Committee, 2009-2007
    • Associate Member, Respiratory Committee, 2008-2006
  • present-2001 American College of Physicians
    • Fellow (FACP), present-2014
    • Mentor, present-2014
    • Judge, ACP National Meetings, Resident/Fellows Clinical Vignette Competition, 2021-2014
  • present-1999: American Society of Clinical Oncology
    • Chair, Membership, ASCO Community of Practice Medical Educators, present-2022
    • Editorial Board, ASCO Digital Education, present-2020
    • Steering Committee, ASCO Oncology Scholars Internship (OSI) Initiative, 2022
    • Membership Advisory Committee, present-2018
      • Early Career Task Force, present-2019
      • Chair-elect, 2020-2021
      • Chair, 2021-2022
    • Volunteer Corp, present-2017
      • ASCO Journal Peer Reviewer Group, present-2017
      • ASCO Technology Research Group, present-2017
      • 2017 Annual Meeting Feedback Group, 2017
      • 2018 Annual Meeting Feedback Group, 2018
    • Education Scholars Program, 2018-2019
    • Work Force Task Force, 2007-2003
    • Fellows Task Force/Career Development Committee, 2003-2000
    • ASCO Educational Symposium Subcommittee, 2003-2001
    • Liaison to Public Issues Committee, 2003-2001
  • 2001-1997: American College of Physicians-American Society of Internal Medicine